DOBMEIER ERIC 4
4 · Atara Biotherapeutics, Inc. · Filed Nov 14, 2023
Insider Transaction Report
Form 4
DOBMEIER ERIC
Director
Transactions
- Purchase
Common Stock
2023-11-10$0.23/sh+446,825$101,340→ 563,325 total
Footnotes (1)
- [F1]Represents the weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $0.2235 to $0.2298. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.